It’s only life – The Shins
The consultants always talk about “quality of life”. Which is fine, but what use is quality, if you don’t have any quantity?
Today, while clearing out a few unpublished bits and bobs on DialM, I found a bookmarked link to something posted a couple of years ago on Gary Petersen’s hugely positive “Myeloma Survival” blog: “The longer you live, the longer you live“.
Gary took survival data from SEER and used it to calculate (death rates and) life expectancy at each year after diagnosis.
We all know the bad news up front. 23% died in the first year, in the data used, and average survival was <5yrs. Though it is quite old data now and I’ve seen more recent things saying yr1 mortality may be down to 10%.
But the good news is in the tail. Almost half (44%) of myeloma patients survived 5 years, and over a quarter (28%) survived 10. After 10 years, only 2.1% of people with myeloma were dying each year… the same as the proportion of the general population who die each year anyway. Though myeloma patients’ relative mortality was more like 7% (2.1% as a proportion of the 28% who had made it that far).
Looking on this negatively, I could point out that the average 75 year old is less likely to die next year than that. But I choose to look positively.
If you have a 7% chance of dying each year, you will, on average (median), live another decade. So the headline is right – the longer you live, the longer you live. You have a 50:50 chance of surviving 5 years with mm. If you do that, you have a two thirds chance of making it to 10. (Having survived the treacherous first 2 years, this data says I already have well over 50% chance of making it from here to 10.) If you live 10 you have a 50:50 of surviving another 10. And presumably improving odds there-on. Until other factors come in to play, of course. The myeloma patient’s objective being, ultimately, to die of something else. It’s worth bearing in mind as well that not only does the data pre-date some recent treatments, but also that it doesn’t factor for age. Given average age at diagnosis is c.70, (and 10% of diagnoses are in people aged 85+) one can assume that those surviving 10+ and 20+ years are disproportionately from the younger end.
This is no consolation at all, I recognise, to families of people who die. Nor is it much consolation to those for whom repeated treatments don’t achieve good remission. Nor much consolation for any of us during periods of relapse – when we are at real, immediate, risk.
But it should massively cheer us up when we are in remission. Our life expectancy is actually increasing by the minute! Which is more than most people can claim. The survival curve for the population as a whole drops more steeply as time goes on, whereas (for a while) ours is at least curving the opposite way.